These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. Al-Dwairi ZN; Al-Quran FA; Al-Omari OY J Prosthodont Res; 2012 Oct; 56(4):272-80. PubMed ID: 22841909 [TBL] [Abstract][Full Text] [Related]
24. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis]. Kutsyk RV; Pavliuk TD Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159 [TBL] [Abstract][Full Text] [Related]
25. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort. Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319 [TBL] [Abstract][Full Text] [Related]
26. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
27. Changes in germ tube formation and cell-surface hydrophobicity of oral Candida dubliniensis isolates following brief exposure to sub-cidal concentrations of polyene and azole antifungal agents. Ellepola AN; Joseph BK; Khan ZU Mycoses; 2013 Jul; 56(4):463-70. PubMed ID: 23405864 [TBL] [Abstract][Full Text] [Related]
28. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. Samaranayake YH; Yau JY; Thein ZM; Jayatilake JA; Yeung KW; Samaranayake LP Med Mycol; 2010 Aug; 48(5):725-34. PubMed ID: 20092419 [TBL] [Abstract][Full Text] [Related]
29. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection. Anil S; Ellepola AN; Samaranayake LP Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477 [TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
31. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus. Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629 [TBL] [Abstract][Full Text] [Related]
32. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Ellepola AN; Panagoda GJ; Samaranayake LP Oral Microbiol Immunol; 1999 Dec; 14(6):358-63. PubMed ID: 10895691 [TBL] [Abstract][Full Text] [Related]
33. Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp. García MT; Llorente MT; Mínguez F; Prieto J Scand J Infect Dis; 2000; 32(6):669-73. PubMed ID: 11200379 [TBL] [Abstract][Full Text] [Related]
34. Denture stomatitis: a role for Candida biofilms. Ramage G; Tomsett K; Wickes BL; López-Ribot JL; Redding SW Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):53-9. PubMed ID: 15243471 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of antifungal agents in tissue conditioners in treating candidiasis. Chow CK; Matear DW; Lawrence HP Gerodontology; 1999 Dec; 16(2):110-8. PubMed ID: 10825850 [TBL] [Abstract][Full Text] [Related]
36. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Johnson EM; Warnock DW; Luker J; Porter SR; Scully C J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758 [TBL] [Abstract][Full Text] [Related]
37. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. Ellepola AN; Samaranayake LP Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451 [TBL] [Abstract][Full Text] [Related]
38. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents. da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267 [TBL] [Abstract][Full Text] [Related]